X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/therapix-biosciences-and-cyntar-ventures-entered-a-non-binding-letter-of-intent-for-the-distribution-of-therapea-in-canada-301201046.html
https://www.prnewswire.com/news-releases/therapix-biosciences-to-collaborate-with-the-university-of-calgary-to-further-examine-its-proprietary-drug-candidate-thx-160-for-pain-301183621.html
https://www.prnewswire.com/il/news-releases/therapix-biosciences-to-collaborate-with-the-university-of-calgary-to-further-examine-its-proprietary-drug-candidate-thx-160-for-pain-301183621.html
https://www.prnewswire.com/news-releases/therapix-biosciences-issues-ceo-letter-to-its-shareholders-301181620.html
https://www.prnewswire.com/news-releases/therapix-biosciences-announces-replacement-of-its-board-of-directors-301116296.html
https://www.prnewswire.com/news-releases/therapix-biosciences-announces-otc-pink-ticker-symbol-trpxy-and-removal-of-injunction-by-israeli-court-301090928.html
https://www.prnewswire.com/news-releases/therapix-biosciences-announces-otc-pink-ticker-symbol-trpxy-and-removal-of-injunction-by-israeli-court-301090928.html
https://www.prnewswire.com/news-releases/therapix-biosciences-receives-notice-of-delisting-and-injunction-from-israeli-court-301086741.html
https://www.prnewswire.com/news-releases/therapix-biosciences-raises-2-6-million-in-private-placement-301085019.html
https://www.prnewswire.com/news-releases/therapix-biosciences-closes-a-joint-venture-transaction-for-its-sleep-indication-301061696.html
Market Place
Share 
